Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

Clinical trial NCT00398411 · COMPLETED

Trial details

NCT number: NCT00398411
Sponsor: University of Cologne
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hodgkin Disease Non-Hodgkin Lymphoma Multiple Myeloma Bacteremia

Start date: 2006-10-01
Primary completion: 2008-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.